Treatments

The Ongoing Challenge of Attracting and Retaining Health Care Providers

By

John Schieszer, MA

Publish Date September 17, 2021

The pandemic has accelerated the number of clinicians retiring from practice.

How COVID-19 Affected Management of Lung Nodule Programs

By

Rosemarie A. Tucci, MSN, RN, AOCN®

Publish Date September 13, 2021

Dramatic changes made to lung nodule programs due to COVID-19 included changes to screening criteria and follow-up protocols, plus a whole new group of patients.

Language in Patient Records Can Convey More Than Medical History

By

Batya Swift Yasgur, MA, LSW

Publish Date September 10, 2021

The language in a patient’s medical record can convey information not only about the patient’s condition but about the attitude of the clinician writing the report.

Cannabidiol Gets Orphan Drug Status for Preventing Ischemia-Reperfusion Injury

By

Steve Duffy

The designation was granted to Revive Therapeutics, a company that specializes in cannabis-based pharmaceuticals.

Chest Tube Placement vs Needle Aspiration for Spontaneous Pneumothorax

By

Bryant Moeller

Both chest tube placement and needle aspiration were considered acceptable treatments for primary spontaneous pneumothorax.

NDA for Novel Amikacin Inhalation Submitted for Rare Lung Infection

By

Steve Duffy

ALIS has previously been designated orphan drug status, breakthrough therapy status and a Qualified Infectious Disease Product.

No Benefit From Prophylactic Antimicrobials in Aspiration Pneumonitis

By

Bradley van Paridon

Use of prophylactic antimicrobial therapy was not associated with a reduction in mortality or transfer to critical care compared with patients managed with supportive care only.

Drainage Duration, Length of Hospital Stay With Different Pneumothorax Treatments

By

Anna Kitabjian

Treatment with a small pigtail catheter may shorten the drainage duration and length of hospital stay in patients with spontaneous pneumothorax.

FDA Approves New CFTR Modulator Therapy for Cystic Fibrosis

By

Britt Gambino

A new cystic fibrosis transmembrane conductance regulator modulator treatment has been approved by the FDA for use in patients aged 12 years and older.

Enteral vs Parenteral Nutrition in Critical Care Requiring Mechanical Ventilation

By

Laurel Ranger

Enteral nutritional support was not clinically superior to parenteral nutritional support in critically ill patients receiving mechanical ventilation.

Examining Compression-to-Ventilation Ratios for Optimal Neurologic, Survival Outcomes

By

Anna Kitabjian

Adults with cardiac arrest have better outcomes with continuous compressions with asynchronous ventilations or compression-to-ventilation ratios of 30:2.